Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/ACR stock hub

ASX/ACR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/ACRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.5M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/ACR

In the news

Latest news · ASX/ACR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-102.2

P25 -118.7P50 -49.4P75 -1.2

ROIC-233.8

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/ACR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

AUD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	43
Enterprise value	AUD 5.8M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU000000ACR3
Last refreshed	2026-05-10
Market cap	AUD 4.5M
Price	AUD 0.01
Price currency	AUD
Rev Per Employee	65,348.84x
Sector	Healthcare
Sic	2834
Symbol	asx/ACR
Website	https://www.acrux.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-52.14%
EV Earnings	-2.45x
EV/FCF	-2.38x
EV/Sales	2.05x
FCF yield	-53.65%
P/B ratio	3.76x
P/S ratio	1.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-204.02%
EBITDA Margin	-196.94%
Gross margin	45.59%
Gross Profit	AUD 1.3M
Gross Profit Growth5 Y	-20.6%
Net Income	AUD -2.4M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-69.93%
Profit Margin	-83.81%
Profit Per Employee	AUD -54,767
ROA	-57.22
Roa5y	-44.85
ROCE	-213.4
ROE	-102.2
Roe5y	-106.8
ROIC	-233.8
Roic5y	-201.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-33.29%
Cagr15y	-30.76%
Cagr1y	-52.2%
Cagr20y	-16.84%
Cagr3y	-40.6%
Cagr5y	-39.88%
Div CAGR3	-9.14%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	250.37x
Revenue Growth Q	1,350x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-17.97x
Revenue Growth5 Y	-19.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.45
Assets	AUD 4.7M
Cash	AUD 946,000
Current Assets	AUD 2.8M
Current Liabilities	AUD 2M
Debt	AUD 2.2M
Debt Equity	AUD 1.83
Debt FCF	AUD -0.91
Equity	AUD 1.2M
Interest Coverage	-19.05
Liabilities	AUD 3.5M
Long Term Assets	AUD 2M
Long Term Liabilities	AUD 1.5M
Net Cash	AUD -1.3M
Net Cash By Market Cap	AUD -27.72
Net Debt Equity	AUD 1.04
Tangible Book Value	AUD 1.2M
Tangible Book Value Per Share	AUD 0
WACC	10.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.35
Net Working Capital	AUD 522,000
Quick ratio	1.26
Working Capital	AUD 712,000
Working Capital Turnover	AUD 1.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-38.31%
Dividend per share	AUD 0
Last Dividend	AUD 0.06

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-98.25%
1Y total return	-52.17%
200-day SMA	0.02
3Y total return	-79.05%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.14%
All Time High	4.77
All Time High Change	-99.77%
All Time High Date	2012-06-20
All Time Low	0.01
All Time Low Change	10%
All Time Low Date	2026-04-27
ATR	0
Beta	0.98
Beta1y	-0.59
Beta2y	0.01
Ch YTD	-26.67
High	0.01
High52	0.03
High52 Date	2025-05-14
High52ch	-59.26%
Low	0.01
Low52	0.01
Low52 Date	2026-04-28
Low52ch	10%
Ma50ch	-10.57%
Price vs 200-day SMA	-26.67%
RSI	43.77
RSI Monthly	30.36
RSI Weekly	34.77
Sharpe ratio	-0.58x
Sortino ratio	-0.75
Total Return	-38.31%
Tr YTD	-26.67
Tr15y	-99.6%
Tr3m	-31.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -5.7M
Operating margin	-204

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	291,728,456%
Net Borrowing	165,000
Shares Insiders	16.67%
Shares Institutions	1.36%
Shares Out	410,608,528
Shares Qo Q	2.14%
Shares Yo Y	38.31%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -2.6M
Average Volume	232,211.35x
Bv Per Share	0
CAPEX	AUD 18,000
Ch10y	-98.25
Ch15y	-99.68
Ch1y	-52.17
Ch20y	-98.35
Ch3m	-31.25
Ch3y	-79.05
Ch5y	-92.14
Ch6m	-26.67
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	199,000
Dollar Volume	2,931.5
Earnings Date	2026-05-25
EBIT	AUD -5.7M
EBITDA	AUD -5.5M
EPS	AUD -0.01
F Score	3
FCF	AUD -2.4M
FCF EV Yield	-42x
FCF Per Share	AUD -0.01
Financing CF	44,000
Fiscal Year End	June
Founded	1,998
Income Tax	AUD 390,000
Investing CF	18,000
Is Primary Listing	1
Last Earnings Date	2026-03-03
Last Report Date	2025-12-31
Ma150	0.01
Ma150ch	-20.29%
Ma20	0.01
Ma20ch	-1.79%
Net CF	-2,379,000
Next Earnings Date	2026-05-25
Open	0.01
Ppne	1,635,000
Price Date	2026-05-06
Ptbv Ratio	3.76
Relative Volume	1.15x
Revenue	2,810,000x
SBC By Revenue	7.69x
Share Based Comp	216,000
Tax By Revenue	13.88x
Tr20y	-97.5%
Tr6m	-26.67%
Volume	266,503
Z Score	-39.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/ACR pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/ACR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/ACR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.4%

Share of float held by funds and institutions

Insider ownership

+16.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+38.3%

Negative means the company is buying back shares.

Technical

ASX/ACR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.8

Neutral momentum band

Price vs 200-day MA

-26.7%

50/200-day relationship not available

Beta (5Y)

0.98

Moves roughly with the market

Sharpe ratio

-0.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/ACR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/ACR stock rating?

asx/ACR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/ACR analysis?

The full report lives at /stocks/asx/ACR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/ACR?

The latest report frames asx/ACR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/ACR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.